.jpg&w=3840&q=75)
.jpg&w=3840&q=75)
.jpg&w=3840&q=75)
.jpg&w=3840&q=75)
.jpg&w=3840&q=75)
Specialty Treatment
Transcranial Magnetic Stimulation (nTMS)
Transcranial Magnetic Stimulation (nTMS)
Feeling like you have tried everything to manage depression? You are not alone. For millions, traditional treatments do not always provide the relief they need. But there is a promising new frontier in mental health: Transcranial Magnetic Stimulation (TMS).
RapidRecovery nTMS is a non-invasive treatment for depression. TMS means stimulating the brain from outside the head using small electrical fields. As a non-drug option, TMS influences the brain and does not alter the rest of your body's chemistry.
Benefits
Non-invasive and medication free
No surgery, drugs, or needles are involved.
Potential for lasting results
Studies show long-term improvements in many cases.
80% response rate and 50% remission
This is truly a precision and personalized treatment, where we can also ensure that the patient receives a specific dose based on their own brain activity.
Targeted therapy
Stimulates specific brain regions linked to depression.
Convenient treatment
Sessions typically are done in an outpatient setting.
Fewer side effects
Compared to medication, TMS has a milder side effect profile.
Relief in 2-3 weeks
Many individuals treated with TMS report feeling relief of depression symptoms within the first 2-3 weeks of treatment.
Personalized RapidRecovery nTMS Therapy Programs
Typically, patients receive five treatments per week over the course of six weeks. After the one-time setup process, each treatment session ranges between three to thirty-seven minutes. Treatment programs may vary by clinic and are personalized for every patient's needs.
TMS is FDA approved and covered by most major insurances—Medicare, Medicaid, Blue Cross, Cigna, United, Aetna, Med Cost, and TRICARE.
We Refer You
Dr. Anand Joshi
Dr. Anand Joshi, twice recognized as a Top Doctor (2020 & 2023), is a forward-thinking psychiatrist specializing in interventional psychiatry and unlocks cutting-edge treatments for optimal patient outcomes. His dedication to progress shines through his recent endeavor, RapidRecovery TMS, making him an early adopter of transcranial magnetic stimulation (TMS).
This non-invasive therapy is FDA approved and revolutionizes depression treatment as an affordable cost, a testament to his commitment to both innovation and accessibility. He attended the University of South Dakota for Residency and Fellowship, and works at Wilmington Psychiatric Associates as well as New Hanover Hospital in addition to other hospitals in North Carolina, Iowa, and Minnesota.
Dr. Joshi completed a mini-fellowship in interventional psychiatry at Emory University.